(Q44492681)

English

Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

author name string

Bruce R Charlesworth

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Andrew J Dowson

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Allan Purdy

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Werner J Becker

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Steen Boes-Hansen

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Markus Färkkilä

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

653-667

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary studies of the pharmacokinetics and tolerability of zolmitriptan nasal spray in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics, dose proportionality, and tolerability of single and repeat doses of a nasal spray formulation of zolmitriptan in healthy volunteers

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zolmitriptan: a review of its use in migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and adverse events of subcutaneous, oral, and intranasal sumatriptan used for migraine treatment: a systematic review based on number needed to treat

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90.

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine?

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sumatriptan. An updated review of its use in migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine. The 042 Clinical Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Migraine and Drug Absorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Optimizing the dose of zolmitriptan (Zomig, 311C90) for the acute treatment of migraine. A multicenter, double-blind, placebo-controlled, dose range-finding study. The 017 Clinical Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/12828501

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00023210-200317090-00005

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44492681&oldid=2206685975"